Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 1;64(4):e191-e196.
doi: 10.1097/JOM.0000000000002463. Epub 2021 Dec 16.

Predictors of COVID-19 Vaccine Uptake in Healthcare Workers: A Cross-Sectional Study in Greece

Petros Galanis  1 , Ioannis Moisoglou, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Daphne Kaitelidou
Affiliations

Predictors of COVID-19 Vaccine Uptake in Healthcare Workers: A Cross-Sectional Study in Greece

Petros Galanis et al. J Occup Environ Med. .

Abstract

Objective: We assessed the uptake of a COVID-19 vaccine and associated factors in a sample of healthcare workers (HCWs).

Methods: An on-line cross-sectional study with 885 HCWs was conducted in Greece during August 2021. We measured socio-demographic data of HCWs and attitudes towards vaccination and the COVID-19 pandemic. A convenience sample was used since the questionnaire was distributed through social media and emails.

Results: The majority of HCWs were vaccinated against the COVID-19 (91.5%). Females and HCWs with a history of seasonal influenza vaccination had a greater probability to get a COVID-19 vaccine. Also, increased self-perceived knowledge regarding the COVID-19 pandemic and increased trust in COVID-19 vaccines were associated with COVID-19 vaccine uptake.

Conclusions: Policymakers and scientists should develop novel strategies to improve COVID-19 vaccine uptake among HCWs.

PubMed Disclaimer

Conflict of interest statement

Writing, review and editing: Petros Galanis, Olga Siskou, Olympia Konstanta-kopoulou, Daphne Kaitelidou The authors report no conflicts of interest.

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Baden LR, El Sahly HM, Essink B, et al. . Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021; 384:403–416. - PMC - PubMed
    1. Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. . Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 2021; 397:671–681. - PMC - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, et al. . Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383:2603–2615. - PMC - PubMed
    1. Wu Z, Hu Y, Xu M, et al. . Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis 2021; 21:803–812. - PMC - PubMed
    1. Galanis P, Vraka I, Siskou O, Konstantakopoulou O, Katsiroumpa A, Kaitelidou D. Predictors of COVID-19 vaccination uptake and reasons for decline of vaccination: a systematic review. Public and Global Health 2021; doi.org: 10.1101/2021.07.28.21261261